FDA approves tadalafil to treat benign prostatic hyperplasia

FDA approves tadalafil to treat benign prostatic hyperplasia

October 7, 2011

FDA has approved tadalafil (Cialis, Eli Lilly) for 3 indications: ED, the signs and symptoms of BPH, and ED and the signs and symptoms of BPH in men who have both conditions.